Evusheld (tixagevimab And Cilgavimab For Injection) - Risk Of Prophylaxis Or Treatment Failure Due To Antiviral Resistance To Specific Sars-cov-2 Subvariants

EVUSHELD, a medication used to prevent or treat COVID-19, is being recalled because it may not work against certain newer SARS-CoV-2 variants due to antiviral resistance. The product was distributed across Canada. This recall is based on new safety information about the medication's effectiveness against specific COVID-19 subvariants.

Product

EVUSHELD (tixagevimab and cilgavimab for injection)

Reason

New safety information - Product safety - COVID

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2023-01-17

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/d7d9cc32-0195-4996-8dd4-4f439b47a177